文献速递系统性红斑狼疮

2019年EULAR/ACR系统性红斑狼疮分类标准评分对死亡和住院的预测效用:不良预后评分(ominosity score)的开发与交叉验证

Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score.
PubMed 文献 · RMD Open · 2024-11-20

在374例新发系统性红斑狼疮(SLE)患者中,2019年EULAR/ACR SLE分类标准评分≥20分与死亡风险(HR 1.17,95%CI 0.67-2.03)和首次住院风险(HR 1.14,95%CI 0.79-1.64)升高均无关。基于分类标准条目开发的不良预后评分对死亡预测一致性为0.76,但未优于仅含年龄和性别的模型(一致性0.77)。

要点

  • 2019年EULAR/ACR SLE分类标准评分≥20分与新发SLE患者的死亡和首次住院风险均无显著关联。
  • 基于SLE分类标准条目开发的不良预后评分对死亡预测一致性为0.76,校准尚可。
  • 不良预后评分的预测能力未优于仅含年龄和性别的模型(一致性0.77)。

核心结论

  • 2019年EULAR/ACR SLE分类标准评分与死亡和住院均无关。
  • 开发的不良预后评分对死亡呈现良好预测,但未优于年龄和性别。

研究设计与样本

  • 基于人群队列纳入新发SLE患者,采用Cox回归评估2019年EULAR/ACR SLE评分与死亡和住院的关联,并开发不良预后评分。
  • 采用最小绝对收缩和选择算子法估计模型系数,通过交叉验证和校准图评估一致性与校准度。

主要发现

  • 在374例新发SLE患者中,EULAR/ACR评分≥20分与≤19分相比,死亡风险HR 1.17(95%CI 0.67-2.03),首次住院风险HR 1.14(95%CI 0.79-1.64)。
  • 死亡不良预后评分纳入年龄、性别、血小板减少、神经精神表现、亚急性皮肤型或盘状狼疮、非瘢痕性脱发、炎性关节炎、肾脏受累、抗磷脂抗体和低补体血症。
  • 不良预后评分模型一致性为0.76,校准尚可;仅含年龄、性别和年份的模型一致性为0.77,年龄和性别为主要预测因素。

关键数值与推荐

  • 2019年EULAR/ACR SLE分类标准评分≥20分定义为阳性阈值。
  • 不良预后评分包含年龄、性别、血小板减少、神经精神表现、亚急性皮肤型或盘状狼疮、非瘢痕性脱发、炎性关节炎、肾脏受累、抗磷脂抗体和低补体血症。
  • 不良预后评分一致性为0.76;仅含年龄、性别和年份的模型一致性为0.77。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) systemic lupus erythematosus (SLE) classification criteria score (≥20 points) has been associated with poor outcomes. We aimed to evaluate its utility as a predictor for mortality and hospitalisation and to derive and validate an ominosity score based on the SLE classification criteria set. METHODS: Incident patients with SLE in a population-based cohort were included. The association between the 2019 EULAR/ACR SLE score and mortality and hospitalisation was assessed using Cox regression adjusted for age, sex and calendar year. An ominosity score for mortality was developed based on the SLE criteria set. The least absolute shrinkage and selection operator method was used to estimate model coefficients. Concordance and calibration were assessed by cross-validation and by plotting the observed event rates against the deciles of predicted probabilities. RESULTS: Among 374 patients with incident SLE, a EULAR/ACR score ≥20 points was not associated with an increased risk of mortality (HR 1.17, 95% CI 0.67 to 2.03) or first hospitalisation (HR 1.14, 95% CI 0.79 to 1.64) compared with a score ≤19 points. The derived ominosity score for mortality included age, sex, thrombocytopaenia, neuropsychiatric manifestations, subacute cutaneous or discoid lupus, non-scarring alopecia, inflammatory arthritis, renal involvement, antiphospholipid antibodies and hypocomplementaemia. This model demonstrated a concordance=0.76 with adequate calibration. Age and sex were the main predictors, as seen in the model including just age, sex and year (concordance=0.77). CONCLUSION: The 2019 EULAR/ACR SLE criteria score was not associated with mortality and hospitalisation. The derived ominosity score for mortality presented good prediction for mortality but was not better than age and sex alone.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Figueroa-Parra G, Hanson AC, Sanchez-Rodriguez A, et al. Utility of the 2019 EULAR/ACR SLE classification criteria for predicting mortality and hospitalisation: development and cross-validation of ominosity score. RMD Open. 2024. PMID: 39572074. doi:10.1136/rmdopen-2024-004833

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。